Leishmaniasis Therapy
Research from X. Serrano-Martin et al broadens understanding of leishmaniasis therapy
Published in TB and Outbreaks Week, February 16th, 2010
New research, 'Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis,' is the subject of a report. "Leishmaniasis is parasitic disease that is an important problem of public health worldwide. Intramuscularly administered glucantime and pentostam are the most common drugs used for treatment of this disease, but they have significant limitations due to toxicity and increasing resistance," investigators in Caracas, Venezuela report.
"A recent breakthrough has been the introduction of orally administered miltefosine for the treatment of visceral, cutaneous, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- American Journal of Pathology
Of swine, birds and men -- pandemic H1N1 flu - Columbia University's Mailman School of Public Health
Use of acetaminophen in pregnancy associated with increased asthma symptoms in children - Dartmouth College
New vaccine effective in preventing TB in African patients with HIV infection - Rockefeller University Press
Immune protein fends off exotic virus - University of Helsinki
Dogs may provide an excellent model for understanding human complex diseases - University of Maryland Medical Center
Survey finds many surgeons suffer injuries from minimally invasive techniques - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
